SCHEMBL1380294

SCHEMBL1380294

O=C(NCCC1CC1)c1ccc(N2CCN(Cc3ccc(F)cc3Cl)CC2)nn1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 11/20 0.70
PRKAA2 P54646 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1378258 0.91 SCD (0.69) SCD
SCHEMBL1377497 0.89 SCD (0.73) SCD
SCHEMBL1379993 0.87 SCD (0.73) SCD
SCHEMBL1377539 0.85 SCD (0.71) SCD
SCHEMBL2466547 0.85 SCD (0.51) SCDPRKAA2
SCHEMBL1377064 0.82 SCD (0.73) SCD
SCHEMBL1376938 0.82 SCD (1.00) SCD
SCHEMBL1380584 0.82 SCD (0.66) SCD
SCHEMBL936802 0.82 MEN1 (0.51) SCDPRKAA2
SCHEMBL994925 0.81 SCD (0.67) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4808616-B2 2011-11-02 JP claimed
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP disclosed
US-7919484-B2 Combination therapy XENON PHARMACEUTICALS INC. (CA) 2011-04-05 US disclosed